evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
2632,GENE_SUMMARY,,"BRD4, a transcriptional coactivator, is altered by amplification and gene fusions in various cancers.",,2017-10-25,,23476,BRD4,bromodomain containing 4,True,ENST00000263377,NM_058243.2,HUNKI,MCAP,CAP,HUNK1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2633,GENE_BACKGROUND,,"BRD4 is a member of the bromodomain and extraterminal (BET) family of proteins, and is important in transcriptional activation and elongation at specific gene enhancer elements (PMID: 20871596). BRD4 binds to acetylated histone lysine motifs and helps recruit members of the transcriptional regulator complex, including P-TEFb and Mediator, which are necessary for PolII-dependent transcriptional elongation (PMID: 24751816). BRD4 has been shown to have a role in inflammation (PMID: 21068722, 25263595), viral gene expression (PMID: 16109376) and heart failure (PMID: 23911322). A subset of regulatory elements termed 'super-enhancers' are bound by high levels of BRD4 and are particularly prone to transcriptional perturbations of BRD4 inhibition (BETi) via small molecules (PMID: 24905006, 23582323). For example, BETi results in significant reduction of MYC downstream activity via its super-enhancer. As such, experimental data has shown that MYC-driven cancers are particularly sensitive to BETi, including multiple myeloma (PMID: 21889194) and medulloblastoma (PMID: 24297863). A chromosomal BRD4-NUT fusion product is a driver of disease in most cases of NUT midline carcinoma and is sensitive to BETi (PMID: 20871596). Resistance to BETi can arise due to BRD4 hyperphosphorylation in breast cancer (PMID: 26735014), and SPOP mutations, which can lead to BRD4 stabilization in prostate cancer (PMID: 28805820).",,2017-10-25,,23476,BRD4,bromodomain containing 4,True,ENST00000263377,NM_058243.2,HUNKI,MCAP,CAP,HUNK1,False,20871596,Selective inhibition of BET bromodomains.,Nature,2017-12-23T20:10:00,468,7327,1067-73,Filippakopoulos P et al,doi: 10.1038/nature09504,,0001-12-23,,28805820,Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.,Nature medicine,2018-09-01T20:17:00,23,9,1063-1071,Dai X et al,doi: 10.1038/nm.4378,,0001-09-01,,25263595,NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis.,Molecular cell,2018-10-23T20:14:00,56,2,219-231,Brown JD et al,doi: 10.1016/j.molcel.2014.08.024,,2018-10-23T02:31:00,,24297863,BET bromodomain inhibition of MYC-amplified medulloblastoma.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-02-15T20:14:00,20,4,912-25,Bandopadhayay P et al,doi: 10.1158/1078-0432.CCR-13-2281,,0001-02-15,,16109376,The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.,Molecular cell,2018-08-19T20:05:00,19,4,523-34,Jang MK et al,,,0001-08-19,,23911322,BET bromodomains mediate transcriptional pause release in heart failure.,Cell,2018-08-01T20:13:00,154,3,569-82,Anand P et al,doi: 10.1016/j.cell.2013.07.013,,0001-08-01,,24751816,Targeting bromodomains: epigenetic readers of lysine acetylation.,Nature reviews. Drug discovery,2018-05-01T20:14:00,13,5,337-56,Filippakopoulos P et al,doi: 10.1038/nrd4286,,0001-05-01,,21889194,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,Cell,2018-09-16T20:11:00,146,6,904-17,Delmore JE et al,doi: 10.1016/j.cell.2011.08.017,,0001-09-16,,23582323,Selective inhibition of tumor oncogenes by disruption of super-enhancers.,Cell,2018-04-11T20:13:00,153,2,320-34,Lovén J et al,doi: 10.1016/j.cell.2013.03.036,,0001-04-11,,21068722,Suppression of inflammation by a synthetic histone mimic.,Nature,2017-12-23T20:10:00,468,7327,1119-23,Nicodeme E et al,doi: 10.1038/nature09589,,0001-12-23,,26735014,Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.,Nature,2018-01-21T20:16:00,529,7586,413-417,Shu S et al,doi: 10.1038/nature16508,,2018-01-21T04:17:00,,24905006,The mechanisms behind the therapeutic activity of BET bromodomain inhibition.,Molecular cell,2018-06-05T20:14:00,54,5,728-36,Shi J et al,doi: 10.1016/j.molcel.2014.05.016,,0001-06-05,
